SLI-F06 not checked
Scarless Laboratories, Inc. · F06-C40
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Skin injection of SLI-F06 at each wound edge after closure of punch biopsy excision.”In the company’s words, NCT05501327 on ClinicalTrials.gov
- Tested for
- Scar, Wound Healing
- Main trialPhase 2
- “Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar appearance”In the company’s words, NCT05501327 on ClinicalTrials.gov
- Other names
- F06-C40
Other drugs for Scar
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 25 Jul 2024 | Dose Regimen Study of SLI-F06 in Healthy Volunteers | |
| Phase 1/2Completed | 18 May 2021 | Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026